The Impact on COVID-19 by Intravenous Bevacizumab Used for Hereditary Hemorrhagic Telangiectasia: A Case Report

Coronavirus disease 2019 (COVID-19) continues as an infectious pandemic. With emphasis on mitigating its impact globally, strategies have been emphasized on prevention to treatment in severe cases. As for pharmacotherapies, many have been researched, with a few being recommended for patients with CO...

Descripción completa

Detalles Bibliográficos
Autores principales: Fanning, Ryan Patrick, Strout, Sara, Rowan, Nicholas R., Weiss, Clifford R., Galiatsatos, Panagis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elmer Press 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239510/
https://www.ncbi.nlm.nih.gov/pubmed/35837077
http://dx.doi.org/10.14740/jmc3948

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9239510/
https://www.ncbi.nlm.nih.gov/pubmed/35837077
http://dx.doi.org/10.14740/jmc3948

Ejemplares similares